1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | C57BL/6 Mouse |
Cat.No | ABC-TC3189 |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Epithelial |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Esophagus |
Disease | Normal |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Mouse Primary Cells |
The C57BL/6 mouse esophageal epithelial cell line is derived from the esophagus of healthy wild-type mice, without disease background. They retain typical epithelial markers, including E-cadherin and ZO-1, confirmed via immunofluorescence. The cells show a normal diploid karyotype (2n=40), verified by G-banding, and are recommended for use below passage 20 to maintain phenotype. Non-tumorigenic and non-metastatic, they are free of mouse-specific viruses such as ectromelia and mouse hepatitis virus. This cell line is widely used to study esophageal epithelial-stromal interactions and diseases such as eosinophilic esophagitis. Its non-cancerous, genetically stable nature makes it ideal for investigating fibrotic responses and epithelial barrier dysfunction in esophageal tissues.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
C57BL/6 mouse esophageal epithelial cells serve as a valuable model system for studying the intricate interactions between epithelial and stromal components. These cells are crucial in unraveling the cellular heterogeneity present in the mouse esophagus. By utilizing C57BL/6 mouse esophageal epithelial cells, researchers can gain insights into the mechanisms driving progressive fibrostenotic diseases, such as eosinophilic esophagitis fibrosis, and deepen our understanding of epithelial biology. This cell model provides a robust platform for investigating the underlying mechanisms and identifying potential therapeutic targets for these diseases affecting the esophageal epithelium.